跳至主要内容
临床试验/NCT06503640
NCT06503640招募中不适用

Coronary Microvascular Dysfunction in Angina Patients With Non-obstructive Coronary Artery Disease

China-Japan Friendship Hospital1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2023年7月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
100
试验地点
1
主要终点
MACE in 12 months

研究概览

简要总结

The goal of this observational study is to explore the incidence and effect on prognosis of coronary microvascular dysfunction in patients present of stable anginal symptoms, a clinical indication for invasive coronary angiography, and no hemodynamically significant epicardial coronary artery disease, defined as fractional flow reserve (FFR) >0.80.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • presence of stable anginal symptoms, a clinical indication for invasive coronary angiography, and no hemodynamically significant epicardial coronary artery disease, defined as fractional flow reserve (FFR) >0.80

排除标准

  • acute myocardial infarction
  • significant valvular heart disease
  • advanced chronic kidney disease
  • patients with significant epicardial coronary artery stenosis (>70% in major vessels by diagnostic coronary angiography) needing percutaneous coronary intervention
  • patients unable to provide written informed consent

结局指标

主要结局

MACE in 12 months

时间窗: 12 months

major adverse cardiovascular events 12 months, including cardiac death, myocardial infarction, and readmission for angina.

次要结局

未报告次要终点

研究者

发起方
China-Japan Friendship Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Jingang Zheng

Head of Cardiology Department

China-Japan Friendship Hospital

研究点 (1)

Loading locations...

相似试验